Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ozanimod 920microgram capsules
0802040BFAAAAAA
|
Ozanimod | Ozanimod | Malignant Disease and Immunosuppression | No data available |
|
Pabal 100micrograms/1ml solution for injection ampoules
0701010W0BBAAAA
|
Pabal | Carbetocin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Pabal 100micrograms/1ml solution for injection vials
0701010W0BBABAB
|
Pabal | Carbetocin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Pacifene 200mg tablets
1001010J0BUAAAD
|
Pacifene | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Paclitaxel 100mg/16.7ml solution for infusion vials
0801050V0AAABAB
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 150mg/25ml solution for infusion vials
0801050V0AAACAC
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 300mg/50ml solution for infusion vials
0801050V0AAADAD
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 30mg/5ml solution for infusion vials
0801050V0AAAAAA
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Painex caplets
0407010X0CGAAAD
|
Painex | Paracetamol combined preparations | Central Nervous System | No data available |
|
Palbociclib 100mg capsules
0801050CBAAABAB
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 100mg tablets
0801050CBAAADAD
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 125mg capsules
0801050CBAAACAC
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 125mg tablets
0801050CBAAAEAE
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 75mg capsules
0801050CBAAAAAA
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 75mg tablets
0801050CBAAAFAF
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Paldesic paracetamol 250mg/5ml oral suspension
0407010H0BCACAC
|
Paldesic | Paracetamol | Central Nervous System | No data available |
|
Palfium 10mg tablets
0407020D0BBABAE
|
Palfium | Dextromoramide tartrate | Central Nervous System | No data available |
|
Palfium 5mg tablets
0407020D0BBAAAD
|
Palfium | Dextromoramide tartrate | Central Nervous System | No data available |
|
Palifermin 6.25mg powder for solution for injection vials
0801000W0AAAAAA
|
Palifermin | Palifermin | Malignant Disease and Immunosuppression | No data available |
|
Paliperidone 150mg/1.5ml inj and Paliperidone 100mg/1ml inj
0402020ABAAAEAE
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | No data available |
|
Palivizumab 100mg inj vials
0503050A0AAAAAA
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palivizumab 100mg/1ml solution for injection vials
0503050A0AAADAD
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palivizumab 50mg inj vials
0503050A0AAABAB
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palivizumab 50mg/0.5ml solution for injection vials
0503050A0AAACAC
|
Palivizumab | Palivizumab | Infections | No data available |
|
Palladone 20mg/1ml solution for injection ampoules
040702050BBAIAM
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.